jump to content jump to footer
Postoperative brain tumor MRI comparing TGSE-BLADE and RESOLVE DWI showing distortion reduction near resection site

University Hospital Tübingen: Improving Postoperative Brain Tumor MRI: TGSE-BLADE vs. RESOLVE DWI

Early MRI scans are critical for patients who have just undergone brain tumor resection to evaluate the surgery's success and plan future treatments. However, the presence of intracranial air often creates "artifacts" or visual distortions that make these scans difficult to read.

In a recent study, Christer Ruff et al. evaluate a more robust imaging technique to solve this problem.

The Challenge: Postoperative Imaging Obstacles

Diffusion-weighted imaging (DWI) is essential for identifying perioperative ischemic changes (minor strokes or tissue damage) near the resection site. Standard techniques like RESOLVE DWI are often impaired by geometric distortions and susceptibility artifacts caused by air-tissue interfaces after surgery. The presence of these distortions complicates the distinction between artifacts, ischemic changes, and postoperative alterations, making it challenging to obtain a clear diagnostic image.

The Study: Comparing TGSE-BLADE and RESOLVE

Researchers conducted a retrospective study of 33 patients who underwent 1.5-Tesla MRI within 48 hours of brain tumor resection. The study compared two advanced techniques:

  • RESOLVE DWI: A common technique that segments data to reduce some distortion.
  • TGSE-BLADE DWI: A non-EPI technique using a "radial" data acquisition strategy designed to be insensitive to magnetic field inhomogeneities.

mint Lesion, a software solution for a standardized and computer-assisted review of imaging and clinical data, was used to perform bidimensional measurements of the resection defect across different imaging sequences.

By comparing these measurements to standard T1-weighted reference images, the team could objectively quantify which DWI technique provided the most accurate, distortion-free view of the surgical site.

Key Outcomes and Findings

The study found that TGSE-BLADE DWI outperformed RESOLVE in several critical areas:

  • Reduced Distortion: TGSE-BLADE showed significantly fewer geometric distortions and artifacts near the resection site compared to RESOLVE (p < 0.001).
  • Higher Accuracy: Measurements of the resection area on TGSE-BLADE images closely matched the T1-weighted reference scans, whereas RESOLVE showed significant discrepancies due to image warping.
  • Diagnostic Confidence: Neuroradiologists reported significantly higher diagnostic confidence and better overall image quality when using TGSE-BLADE.
  • Trade-offs: While RESOLVE DWI provided a slightly higher signal-to-noise ratio (SNR), the clarity and lack of distortion in TGSE-BLADE made it the superior tool for clinical assessment.

Conclusion: A Possible New Standard for Postoperative Care

The study concludes that TGSE-BLADE DWI is a robust alternative to conventional sequences for postoperative brain imaging. By minimizing artifacts caused by intracranial air, it allows doctors to clearly distinguish between expected post-surgical changes and actual ischemic brain damage. This leads to more accurate follow-up assessments and improved long-term patient care.

 

Read the original publication here.

Christer Ruff, Till-Karsten Hauser, Paula Bombach, Daniel Vogl, Constantin Roder, Frank Paulsen, Deborah Staber, Vivien Richter, Leonie Zerweck, Ulrike Ernemann, Georg Gohla. “A comprehensive quantitative and qualitative assessment of TGSE-BLADE DWI in postoperative imaging following intracranial tumor resection.” European Journal of Radiology, Volume 196, 2026,  ttps://doi.org/10.1016/j.ejrad.2026.112659.

Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Read more
Onur Özek from Mint Medical discusses the challenges, requirements, and future of lung cancer screening in Germany in an interview with RadMag.
In the latest RadMag Special Edition, Onur Özek discusses structured reporting, AI integration, second-reader workflows, interoperability, and the importance of end-to-end workflow management for lung cancer.
RadMag Special Edition: Onur Özek on the Challenges of Lung Cancer Screening in Germany
With the nationwide rollout of Germany’s lung cancer screening, radiology providers are facing new challenges. Structured reporting, mandatory second…
Read more
Integrated prostate cancer workflow connecting radiology, urology, and pathology through structured reporting, MRI-guided biopsy, longitudinal follow-up, and AI-supported analysis.
mint Lesion supports an end-to-end prostate cancer workflow by connecting radiology, urology, and pathology within a unified digital environment. The platform enables structured mpMRI reporting, MRI/ultrasound fusion biopsy workflows, FHIR-based interoperability, active surveillance, and AI-supported quantification of metastatic disease.
Be Central to the Insight: A Structured, Data-Driven Approach to the End-to-End Prostate Pathway
Digital Integration for Multidisciplinary Teams  In the complex journey of prostate cancer diagnostics, the data contributed by every department is…
Read more
scroll-top